Topical butyrate for acute radiation proctitis: randomised, crossover trial.
Background: No available therapy has, as yet, proven effective to treat acute radiation proctitis (ARP) following radiation therapy for malignant pelvic disease. We assessed whether sodium butyrate enemas, at a dose of 80 mmol/L (80 mL/24 h), might offer effective treatment for this condition.Method...
| Publicado en: | Lancet Vol. 356; no. 9237; pp. 1232 - 1236 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | clinical trial research randomized controlled trial Journal Article |
| Publicado: |
Lancet
10/7/2000
|
| Acceso en línea: | Ver este registro en EBSCOhost |